Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

Wire brush snares are best for collecting Eurasian Lynx hair for DNA analysis.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

AB+ blood group is more common in alopecia areata patients.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Older age and certain lifestyles are linked to thinner, weaker hair, while how you see your hair relates to its thickness.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.